News + Filings Transactions
|
SEIDENBERG BETH C
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
| 05/24/2023 | Progyny, Inc. | PGNY | Grant | Common Stock | 5.1k | $0.00 | $0 | | 05/24/2023 |
| 05/24/2023 | Progyny, Inc. | PGNY | Grant | Stock Option (Right to Buy) | 19.7k | $38.24 | $753.7k | | 05/24/2023 |
| 05/24/2023 | Progyny, Inc. | PGNY | Grant | Stock Option (Right to Buy) | 3.3k | $38.24 | $124.7k | | 05/24/2023 |
| 05/10/2023 | Vera Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 20k | $7.70 | $154k | | 05/10/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Series B Redeemable Convertible Preferred Stock | 2.4M | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Series C Redeemable Convertible Preferred Stock | 2M | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Series A Redeemable Convertible Preferred Stock | 4.1M | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Purchase | Common Stock | 60k | $18.00 | $1.1M | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Purchase | Common Stock | 1.2M | $18.00 | $22.5M | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Conversion | Common Stock | 8.5M | $0.00 | $0 | See footnote | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (disposition) | Director Stock Option (right to buy) | 23.2k | $18.00 | $418.4k | | 05/09/2023 |
| 05/09/2023 | ACELYRIN, Inc. | | Other (acquisition) | Director Stock Option (right to buy) | 23.2k | $18.00 | $418.4k | | 05/09/2023 |
| 05/04/2023 | ACELYRIN, Inc. | | Grant | Director Stock Option (right to buy) | 23.2k | $18.00 | $418.4k | | 05/04/2023 |
| 03/30/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 2.3k | $7.24 | $16.7k | See Footnote | 03/30/2023 |
| 03/20/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 15.3k | $7.21 | $110k | See Footnote | 03/17/2023 |
| 03/17/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 74k | $7.12 | $526.9k | See Footnote | 03/17/2023 |
| 03/16/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 60.1k | $7.09 | $426.3k | See Footnote | 03/15/2023 |
| 03/15/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 32.8k | $7.12 | $234k | See Footnote | 03/15/2023 |
| 03/03/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 1000 | $7.25 | $7.2k | See footnote | 03/03/2023 |
| 02/23/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 200 | $7.24 | $1.4k | See footnote | 02/23/2023 |
| 02/08/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 45.4k | $7.22 | $327.5k | See footnote | 02/03/2023 |
| 02/07/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 88k | $7.08 | $622.7k | See footnote | 02/03/2023 |
| 02/06/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 131.6k | $7.03 | $925.2k | See footnote | 02/03/2023 |
| 02/03/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 46.2k | $7.24 | $334.2k | See footnote | 02/03/2023 |
| 10/24/2022 | Progyny, Inc. | PGNY | Grant | Common Stock | 4.1k | $0.00 | $0 | | 10/24/2022 |
| 10/24/2022 | Progyny, Inc. | PGNY | Grant | Stock Option (Right to Buy) | 16.8k | $38.22 | $642.9k | | 10/24/2022 |
| 10/24/2022 | Progyny, Inc. | PGNY | Grant | Stock Option (Right to Buy) | 1.9k | $38.22 | $72.5k | | 10/24/2022 |
| 06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 20.5k | $0.00 | $0 | | 06/23/2022 |
| 06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 31.5k | $7.35 | $231.5k | | 06/23/2022 |
| 05/24/2022 | Vera Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 9.9k | $16.14 | $160.2k | | 05/24/2022 |
| 03/03/2022 | Progyny, Inc. | PGNY | Gift | Common Stock | 23k | $0.00 | $0 | | 10/24/2022 |
| 03/03/2022 | Progyny, Inc. | PGNY | Gift | Common Stock | 23k | $0.00 | $0 | See footnote | 10/24/2022 |
| 12/22/2021 | Progyny, Inc. | PGNY | Other (acquisition) | Common Stock | 15.2k | $0.00 | $0 | | 12/22/2021 |
|
|